Healthcare of Ontario Pension Plan Trust Fund Acquires New Stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 82,217 shares of the company’s stock, valued at approximately $4,185,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. BNP Paribas Financial Markets increased its stake in shares of Establishment Labs by 32,968.7% during the 1st quarter. BNP Paribas Financial Markets now owns 97,222 shares of the company’s stock worth $4,949,000 after purchasing an additional 96,928 shares in the last quarter. Stableford Capital II LLC purchased a new stake in shares of Establishment Labs during the 1st quarter valued at $1,568,000. Kornitzer Capital Management Inc. KS increased its holdings in shares of Establishment Labs by 26.3% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 389,160 shares of the company’s stock worth $10,075,000 after buying an additional 81,155 shares during the last quarter. Brown Advisory Inc. raised its position in shares of Establishment Labs by 63.9% in the 4th quarter. Brown Advisory Inc. now owns 2,428,792 shares of the company’s stock worth $62,881,000 after buying an additional 946,612 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in Establishment Labs by 357.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 30,247 shares of the company’s stock valued at $783,000 after acquiring an additional 23,639 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on ESTA shares. Citigroup dropped their price target on Establishment Labs from $60.00 to $50.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. Mizuho increased their target price on shares of Establishment Labs from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, June 6th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Establishment Labs currently has an average rating of “Moderate Buy” and an average target price of $54.00.

Establishment Labs Stock Performance

NASDAQ:ESTA opened at $48.14 on Friday. The business has a 50 day simple moving average of $47.53 and a 200 day simple moving average of $46.04. The company has a debt-to-equity ratio of 3.38, a quick ratio of 2.73 and a current ratio of 4.24. Establishment Labs Holdings Inc. has a 12-month low of $16.96 and a 12-month high of $73.00.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings results on Wednesday, May 8th. The company reported ($0.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.65) by $0.07. Establishment Labs had a negative net margin of 53.12% and a negative return on equity of 206.05%. The company had revenue of $37.17 million during the quarter, compared to the consensus estimate of $35.61 million. During the same quarter in the previous year, the company posted ($0.48) earnings per share. The company’s revenue for the quarter was down 20.1% compared to the same quarter last year. On average, equities analysts anticipate that Establishment Labs Holdings Inc. will post -1.79 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Quiros Juan Jose Chacon sold 6,839 shares of Establishment Labs stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $45.30, for a total transaction of $309,806.70. Following the sale, the chief executive officer now owns 218,896 shares of the company’s stock, valued at $9,915,988.80. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In the last 90 days, insiders sold 14,346 shares of company stock worth $647,806. Insiders own 11.44% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.